comparemela.com

Latest Breaking News On - Pharmaceuticals nec trbc level 5 - Page 11 : comparemela.com

Mexico to receive 2 2 mln AstraZeneca vaccines under COVAX plan

Bayer sticks to $2 billion provisions taken for class plan

Bayer hit by failure to cap risk from weedkiller cases

4 Min Read FRANKFURT (Reuters) -Bayer shares dropped as much as 5% on Thursday after a U.S. judge rejected its plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer. The German group called into question the future sale of glyphosate-based products to gardeners in the U.S., and said it would review plans to settle around 30,000 legal claims, after the judge called Bayer’s plan to end years of litigation “unreasonable” on Wednesday. “We will continue to assess financial risks as we move forward,” finance chief Wolfgang Nickl said in an analyst call, when asked if the estimate of the potential financial burden had been revised.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.